The Screens Look Worse Than the Breadth
Ugly action in technology is dragging down names that have nothing to do with AI.
Ugly action in technology is dragging down names that have nothing to do with AI.
Four issues have arrived at the same time. But they are not the same problem. Here’s what to know.
Semiconductor weakness lifted the hyperscalers again while the market waits on the Fed.
Breadth holds up while chips fall, and this biotech chart is setting up ahead of earnings season.
The negative reaction to good earnings reports last week may have created better conditions for the big reports that hit this week.
Let’s look at the No. 1 mistake investors make when buying the dip — and how to avoid it.
The gloom is thick, but fundamentals are not the problem. Plus, an important reminder for investors after a trying week.
While the technical damage is significant in places, the selling is driven by CapEx concerns, not deteriorating fundamentals.
Rising rates and capex fears hit at the same time, but the rotation is limiting the damage.
Dislocations driven by market conditions rather than fundamentals are creating my shopping list.